These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 16108306
1. Ethnicity and breast cancer in Hawaii: increased survival but continued disparity. Braun KL, Fong M, Gotay C, Pagano IS, Chong C. Ethn Dis; 2005; 15(3):453-60. PubMed ID: 16108306 [Abstract] [Full Text] [Related]
2. Ethnic differences in breast cancer in Hawai'i: age, stage, hormone receptor status, and survival. Braun KL, Fong M, Gotay CC, Chong CD. Pac Health Dialog; 2004 Sep; 11(2):146-53. PubMed ID: 16281692 [Abstract] [Full Text] [Related]
3. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI. Cancer; 2005 Jun 01; 103(11):2241-51. PubMed ID: 15844176 [Abstract] [Full Text] [Related]
4. Breast cancer treatment among women of different ethnicity in Hawaii. Issell BF, Maskarinec G, Pagano I, Gotay CC. Cancer Invest; 2005 Jun 01; 23(6):497-504. PubMed ID: 16203657 [Abstract] [Full Text] [Related]
5. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Li CI, Malone KE, Daling JR. Cancer Epidemiol Biomarkers Prev; 2002 Jul 01; 11(7):601-7. PubMed ID: 12101106 [Abstract] [Full Text] [Related]
7. Body weight correlates with mortality in early-stage breast cancer. Enger SM, Greif JM, Polikoff J, Press M. Arch Surg; 2004 Sep 01; 139(9):954-58; discussion 958-60. PubMed ID: 15381612 [Abstract] [Full Text] [Related]
8. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion]. Zhao WH, Xu BH, Zhang P, Li Q, Zhao LM, Sun Y. Zhonghua Zhong Liu Za Zhi; 2007 Feb 01; 29(2):137-40. PubMed ID: 17645853 [Abstract] [Full Text] [Related]
9. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study. O'Malley CD, Le GM, Glaser SL, Shema SJ, West DW. Cancer; 2003 Mar 01; 97(5):1303-11. PubMed ID: 12599239 [Abstract] [Full Text] [Related]
14. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C. Cancer Epidemiol Biomarkers Prev; 2006 Dec 01; 15(12):2482-8. PubMed ID: 17164374 [Abstract] [Full Text] [Related]
15. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM. J Natl Cancer Inst; 2005 Sep 07; 97(17):1254-61. PubMed ID: 16145046 [Abstract] [Full Text] [Related]
16. The importance of temporal effects in evaluating the prognostic impact of joint ERPR expression in premenopausal women with node-positive breast cancer. Ouyang Y, Li D, Pater JL, Levine M. Breast Cancer Res Treat; 2005 Jul 07; 92(2):115-23. PubMed ID: 15986120 [Abstract] [Full Text] [Related]
18. Demographic, treatment, and survival patterns for Native Hawaiians with lung cancer treated at a community medical center from 1995 to 2001. Liu DM, Kwee SA. Pac Health Dialog; 2004 Sep 07; 11(2):139-45. PubMed ID: 16281691 [Abstract] [Full Text] [Related]
19. Is triple negative a prognostic factor in breast cancer? Nishimura R, Arima N. Breast Cancer; 2008 Sep 07; 15(4):303-8. PubMed ID: 18369692 [Abstract] [Full Text] [Related]